edoc

Items where Author is "Spigelman, Melvin"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2019 | 2015
Number of items: 2.

2019

Tweed, Conor D. and Dawson, Rodney and Burger, Divan A. and Conradie, Almari and Crook, Angela M. and Mendel, Carl M. and Conradie, Francesca and Diacon, Andreas H. and Ntinginya, Nyanda E. and Everitt, Daniel E. and Haraka, Frederick and Li, Mengchun and van Niekerk, Christo H. and Okwera, Alphonse and Rassool, Mohammed S. and Reither, Klaus and Sebe, Modulakgotla A. and Staples, Suzanne and Variava, Ebrahim and Spigelman, Melvin. (2019) Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial. The lancet Respiratory medicine, 7 (12). pp. 1048-1058.

2015

Dawson, Rodney and Diacon, Andreas H. and Everitt, Daniel and van Niekerk, Christo and Donald, Peter R. and Burger, Divan A. and Schall, Robert and Spigelman, Melvin and Conradie, Almari and Eisenach, Kathleen and Venter, Amour and Ive, Prudence and Page-Shipp, Liesl and Variava, Ebrahim and Reither, Klaus and Ntinginya, Nyanda E. and Pym, Alexander and von Groote-Bidlingmaier, Florian and Mendel, Carl M.. (2015) Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment : a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis. Lancet, Vol. 385, no. 9979. pp. 1738-1747.

This list was generated on Thu Feb 20 08:31:29 2020 CET.